001     203112
005     20210129220302.0
024 7 _ |a 10.1016/j.bbamem.2015.01.015
|2 doi
024 7 _ |a 0005-2736
|2 ISSN
024 7 _ |a 1879-2642
|2 ISSN
024 7 _ |a WOS:000352041100006
|2 WOS
037 _ _ |a FZJ-2015-05136
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Hung, Yu-Fu
|0 P:(DE-Juel1)140558
|b 0
245 _ _ |a Dengue virus NS4A cytoplasmic domain binding to liposomes is sensitive to membrane curvature
260 _ _ |a Amsterdam
|c 2015
|b Elsevier
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1449218571_28392
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Dengue virus (DENV) infection is a growing public health threat with more than one-third of the world's population at risk. Non-structural protein 4A (NS4A), one of the least characterized viral proteins, is a highly hydrophobic transmembrane protein thought to induce the membrane alterations that harbor the viral replication complex. The NS4A N-terminal (amino acids 1–48), has been proposed to contain an amphipathic α-helix (AH). Mutations (L6E; M10E) designed to reduce the amphipathic character of the predicted AH, abolished viral replication and reduced NS4A oligomerization. Nuclear magnetic resonance (NMR) spectroscopy was used to characterize the N-terminal cytoplasmic region (amino acids 1–48) of both wild type and mutant NS4A in the presence of SDS micelles. Binding of the two N-terminal NS4A peptides to liposomes was studied as a function of membrane curvature and lipid composition. The NS4A N-terminal was found to contain two AHs separated by a non-helical linker. The abovementioned mutations did not significantly affect the helical secondary structure of this domain. However, they reduced the affinity of the N-terminal NS4A domain for lipid membranes. Binding of wild type NS4A(1–48) to liposomes is highly dependent on membrane curvature.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Schwarten, Melanie
|0 P:(DE-Juel1)132019
|b 1
700 1 _ |a Schünke, Sven
|0 P:(DE-Juel1)132020
|b 2
700 1 _ |a Thiagarajan-Rosenkranz, Pallavi
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Hoffmann, Silke
|0 P:(DE-Juel1)132003
|b 4
700 1 _ |a Sklan, Ella H.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Willbold, Dieter
|0 P:(DE-Juel1)132029
|b 6
700 1 _ |a König, Bernd
|0 P:(DE-Juel1)132009
|b 7
|e Corresponding author
|u fzj
773 _ _ |a 10.1016/j.bbamem.2015.01.015
|g Vol. 1848, no. 5, p. 1119 - 1126
|0 PERI:(DE-600)2209384-9
|n 5
|p 1119 - 1126
|t Biochimica et biophysica acta / Biomembranes
|v 1848
|y 2015
|x 0005-2736
856 4 _ |u https://juser.fz-juelich.de/record/203112/files/Hung%2C%20Schwarten%2C%20Sch%C3%BCnke%2C%20Thiagarajan-Rosenkranz%2C%20Hoffmann%2C%20Sklan%2C%20Willbold%2C%20K%C3%B6nig_2015.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203112/files/Hung%2C%20Schwarten%2C%20Sch%C3%BCnke%2C%20Thiagarajan-Rosenkranz%2C%20Hoffmann%2C%20Sklan%2C%20Willbold%2C%20K%C3%B6nig_2015.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:203112
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)140558
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)132019
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)132003
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)132029
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)132009
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BBA-BIOMEMBRANES : 2013
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21